Cytokine Profiling of Erythroderma Biopsies Reveals Types 2 and 17 Immune Activation Status
We developed a Type 2/17 immune signature classifier based on cytokine profiling, which showed that cases of erythroderma fall within distinct categories of immune activation. This categorization may have utility in guiding clinical decisions.
Authors
- Tatsiana Pukhalskaya (ORCID: https://orcid.org/0000-0001-6318-460X)
- Jarish N. Cohen (ORCID: https://orcid.org/0000-0002-6043-2177)
- Jeffrey P. North (ORCID: https://orcid.org/0000-0003-3973-5314)
- Michael T. Tetzlaff (ORCID: https://orcid.org/0000-0001-7899-4138)
- Mitchell J. Finkelstein (ORCID: https://orcid.org/0009-0000-8861-3589)
- Dacia A. Miyake‐Caballero
Institutions
- Cooper Medical School of Rowan University (US)
Publication Details
- Journal
- Journal of Cutaneous Pathology
- Published
- 2024-12-12
- DOI
- https://doi.org/10.1111/cup.14775
- Citations
- 1
- Primary Topic
- Cutaneous lymphoproliferative disorders research
- Type
- article
- Field-Weighted Citation Impact
- 0.53